John Griffin‘s Blue Ridge Capital has initiated a position in Zulily Inc (NASDAQ:ZU), a new filing with the Securities and Exchange Commission revealed. The fund reported ownership of a total of 799,811 shares, which represent 6.05% of the company’s class A common stock. The company started trading on the NASDAQ market earlier in November, and the value of the passive stake held by Blue Ridge amounts to approximately $29.7 million, at the current stock price of the company.
E-commerce company, Zulily Inc (NASDAQ:ZU) via its sites and mobile applications provides online shopping services for moms, being also one of the largest e-commerce enterprises in the United States. The company filed for its Initial Public Offering at the beginning of October. Overall, during the IPO, the company issued over 13.2 million class A shares, worth $20.00 apiece, the total value amounting to $264.5 million. Since shares of the company began trading publicly, the stock of the company edged down by around 1.8%.
Zulily Inc (NASDAQ:ZU) had around 2.6 million active cutomers at the end of September, double from 1.3 million customers a year ago, the company stated in its S-1 form filed with the SEC. Zulily Inc (NASDAQ:ZU) earned revenue worth $215 per one active customer for 12 months ended September 2012, which represents an over 10% increase from $195 gained a year ago.
Among other recent moves made by Mr. Griffin and Blue Ridge Capital we can mention their increase in the Avis Budget Group Inc. (NASDAQ:CAR) holding to 6.6 million shares, from 4.3 million shares held earlier. Currently, Blue Ridge holds 6.2% of the outstanding stock of the company.
In the latest round of 13F filings, Blue Ridge revealed that it is still bullish on Priceline.com Inc (NASDAQ:PCLN), which is the largest investment in its equity portfolio. The fund owns 404,000 shares of Priceline, with a reported value of $408 million. The second-, and third-largest positions are represented by American International Group Inc (NYSE:AIG) in which the fund holds 7.3 million shares, and Thermo Fisher Scientific Inc. (NYSE:TMO), in which Blue Ridge reduced its stake, but still owns 3.7 million shares, worth $340 million.